The most common cancer among Canadian women in 2010 is breast cancer.

DURHAM, N.C., Dec. 10, 2015 (GLOBE NEWSWIRE) -- Argos Therapeutics Inc. (Nasdaq:ARGS) ("Argos"), an immunooncology company focused on the development and commercialization of fully individualized immunotherapies for the treatment of cancer based on the Arcelis® technology platform, today announced its independent data monitoring committee (IDMC) has recommended the continuation of the company's pivotal phase 3 ADAPT clinical trial of AGS-003 for the treatment of metastatic renal cell carcinoma (mRCC) based on results of the committee's second planned interim data analysis. "The ADAPT phase 3 trial to evaluate AGS-003 in front line mRCC, the largest global trial ever performed in newly diagnosed, unfavorable risk mRCC patients, continues to progress nicely," said Dr. Figlin, the Steven Spielberg Family chair in hematology oncology, professor of medicine and biomedical sciences at the Cedars-Sinai Samuel Oschin Comprehensive Cancer Institute and the principal investigator for the ADAPT trial. "We anticipate that we are approaching the mid-point for the expected number of events and look forward to the next interim review of the trial data in approximately six months."

Chemotherapy is one of the most commonly used ways to treat cancer.

Colorectal cancer is the second most common cancer diagnosed in males and females (AIHW, 2012a)....

American Society for the Control of Cancer, September 1918, 1 (6.

NuCana’s ADSs have been approved for listing on the NASDAQ Global Select Market and are expected to begin trading under the symbol “NCNA” on September 28, 2017. The offering is expected to close on October 2, 2017, subject to customary closing conditions.

However, the human body can be altered by a genetic mutation.

The recent certifications are an important milestone for Green Biologics’ BioPure™ n-butanol and acetone, which are entirely produced using renewable feedstocks. Consumers and retailers are increasingly demanding products produced from natural or sustainable ingredients. Both n-butanol and acetone can also serve as additives and solvents in personal care, cosmetic, and both household and industrial cleaning products. For cosmetics, while acetone is most often used as a nail polish remover, BioPure™ n-butanol can be combined with acids derived from natural plant based oilsto produce a wide array of 100 percent renewable butyl esters. These esters can be utilized in natural lipsticks, moisturizers, and nail polishes. Butyl esters are also utilized as aroma chemicals in fragrance products and flavor additives within the food industry.

Proper cancer treatment, especially prostate cancer in men is possible as reviewed in this article.

The purpose of the lungs is to help one breathe....

Once a treatment is developed and the patient completes his or her recommended treatment plan, their doctors should recommend further treatment and therapy to ensure that the patient doesn’t develop metastasis or a reoccurrence of cancer.

Not many parents see the need to research about cancer.

Colon cancer, one of the leading causes of cancer death in the United States, has been used as the choice for the cancer to identify and treat in certain studies.

On the contrary, nearly thirteen thousand kids get cancer each year.

Nickolas Papadopoulos, Ph.D. Associate Professor, Department of Oncology, Director of Translational Genetics, Ludwig Center for Cancer Genetics & Therapeutics, Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Institutions, CRB1, Room 585, 1650 Orleans Street, Baltimore, MD 21231

Colon cancer has always been an issue in the world.

Thus, the links between telomeres and cancer and the discoveries being made on them is changing the world through current and future applications that have implications for cancer treatment, society, the economy, and technology....

Thyroid cancer is the tenth most common cancer in Canada [2].

Through previous experiments, treatments for people with colon cancer have been utilized, but still present issues associated with the treatment is the proper identification of cancer cells and the high toxicity associated with some of the treatments and the effect on the human body....

The most common type of breast cancer is ductal carcinoma in situ.

Dr. Nakamura received his MD and PhD from Osaka University, and became Head of the Biochemistry Department, at the Cancer Institute, Japanese Foundation for Cancer Research in 1989. He was appointed as a professor at the Institute of Medical Science, University of Tokyo in 1994 and the Department of Medicine at the University of Chicago in 2012. From January to December 2011, Dr. Nakamura was Special Advisor to the Cabinet Secretary General, Office of Medical Innovation, Cabinet Secretariat, Government of Japan. Dr. Nakamura received the Keio Medical Science Prize and the Tomizo Yoshida Award of the Japanese Cancer Association. He is a member of the Association of American Physicians.